Diabetic medicine : a journal of the British Diabetic Association
-
The following article, published online on 19 June 2014 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the Editor in Chief of Diabetic Medicine, Richard Holt and John Wiley and Sons Ltd. The retraction has been agreed due to notification of dual publication. References Derosa G, Bonaventura A, Bianchi L, Romano D, Fogari E, D'Angelo A, Maffioli P. ⋯ Derosa G, Bonaventura A, Bianchi L, Romano D, Fogari E, D'Angelo A, Maffioli P. Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with type 2 diabetes. Metabolism 2014; 63: 957-967.
-
To provide comprehensive real-world evidence on societal diabetes-attributable costs in Denmark. ⋯ Nearly half of the total costs of patients with diabetes can be attributed directly to their diabetes. The majority of costs are incurred among patients with major complications pointing to the importance of secondary preventive efforts among patients with diabetes.
-
Randomized Controlled Trial
Optimizing diabetes control in people with Type 2 diabetes through nurse-led telecoaching.
To study the effect of a target-driven telecoaching intervention on HbA1c and other modifiable risk factors in people with Type 2 diabetes. ⋯ Nurse-led telecoaching improved glycaemic control, total cholesterol levels and BMI in people with Type 2 diabetes. Twelve months after the intervention completion, there were sustained improvements in glycaemic control.